Bridgewater’s New Q2 2025 Positions: Dalio’s Multi-Asset Playbook for a Tectonic Rate Shift

This article is proudly sponsored by Lake Region State College!

Bridgewater’s New Q2 2025 Positions: Dalio’s Multi-Asset Playbook for a Tectonic Rate Shift

The Fed’s 2025 stance has been clear: hold the line on rates until inflation is firmly under control. Yet, markets see the ice starting to crack — with consensus building for small, steady cuts by year-end. Ray Dalio’s Bridgewater Associates just dropped its Q2 2025 13F, revealing a sprawling slate of new positions across tech, energy, banks, industrials, and real estate.

It’s classic Dalio: broad diversification, geographic reach, and an eye toward what happens when liquidity conditions start to ease.

1. High-Quality Tech as a Duration Bet

Bridgewater initiated several positions in software and semiconductor leaders — names that tend to re-rate first when discount rates drop:

Arm Holdings (ARM) — chip IP powerhouse riding AI, IoT, and smartphone design wins.
Intuit (INTU) — small business and consumer finance software, sticky subscription revenues.
Keysight (KEYS) — testing and measurement equipment for electronics and wireless. Demand for testing often rises when financing becomes cheaper, demand for electronics rises, etc..
Okta (OKTA), HubSpot (HUBS), Veeva (VEEV), Roku (ROKU), Pegasystems (PEGA) — niche software and platform players with recurring revenue models.
Hardware/design tilt with Jabil (JBL), Silicon Labs (SLAB), Juniper (JNPR), Qorvo (QRVO), and Allegro MicroSystems (ALGM).

These are not speculative microcaps — they’re profitable or strategic leaders in their categories, giving Bridgewater upside in a gradual easing cycle without abandoning balance sheet quality.

2. Energy and Commodities as Inflation Insurance

Even as the market sniffs rate cuts, Dalio keeps his inflation hedge alive:

EQT Corp (EQT) and Antero Resources (AR) — U.S. natural gas producers with supply leverage.
Equinor (EQNR) and Marathon Petroleum (MPC) — integrated and refining exposure.
CF Industries (CF), Nutrien (NTR), Tronox (TROX), Vulcan Materials (VMC) — agricultural nutrients, industrial minerals, and construction aggregates.

This mix balances long-cycle industrial demand with near-term pricing power if commodity markets tighten again.

Also, in general, if the Fed cuts too early and the economy overall slows down too much, we’re likely to have a brief uptick in commodities as inflation stays sticky prior to the economy entering full-on recession territory.

3. Banks and Financials — Playing the Steepener

Bridgewater opened a long list of regional and national bank positions — KeyCorp (KEY), Webster (WBS), Texas Capital (TCBI), Associated Banc (ASB), Comerica (CMA), Truist (TFC), Zions (ZION), Prosperity (PB), Cullen/Frost (CFR), PNC (PNC), First Horizon (FULT), Hope Bancorp (HOPE), and others.

The macro read: a gradual steepening of the yield curve (short rates falling faster than long) could lift net interest margins and loan growth without triggering a credit bust.

4. Industrials & Infrastructure — Late-Cycle Stamina

Dalio also planted stakes in names poised to benefit from infrastructure spend and supply-chain rebuilds:

Sarcos Technology (SARO), Hexcel (HXL), Matson (MATX), Embraer (ERJ), Teledyne (TDY), Emerson (EMR), Granite Construction (GVA).
Energy infrastructure with Bloom Energy (BE).

These companies give cyclical upside if fiscal spending remains robust into 2026 and, of course, enjoy gradual easing.

5. Real Estate — Bottom-Fishing REITs

REITs have been hammered by higher rates, but Bridgewater is buying early:

National Retail Properties (NNN), W.P. Carey (WPC), CubeSmart (CUBE).
These offer income now and potential cap rate compression if borrowing costs fall.

6. Consumer Discretionary — Selective and Tactical

Bridgewater’s new consumer names are a mix of consumer discretionary and steady brands:

Ulta Beauty (ULTA), Lyft (LYFT), Chewy (CHWY), Foot Locker (FL), Steven Madden (SHOO), Mister Car Wash (MCW), Stellantis (STLA).

Many are trading at compressed multiples, offering asymmetric upside if real wages keep rising into a rate-cutting cycle.

7. Healthcare — Niche and Strategic

Dalio added targeted stability-focused healthcare exposures:

Vertex (VRTX) for biotech innovation,
Amgen (AMGN) for large-cap defensive growth,
Dentsply Sirona (XRAY) for dental products,
Temenos (TEM) for healthcare IT.

The Macro Thread

Bridgewater’s Q2 2025 new positions form a layered macro hedge:

Growth Exposure for Rate Cuts: Quality tech and select consumer names that benefit when capital costs drop.
Inflation and Geopolitical Hedge: Energy, commodities, and ag plays to protect against supply shocks.
Steepener and Credit Normalization: Regionals and diversified banks positioned for better margins when the Fed shifts.
Income and Duration Leverage: Early REIT entries for yield and capital appreciation if cap rates compress.

Bottom Line

Dalio’s not making a binary bet on “boom or bust” — he’s building a portfolio that profits if the Fed engineers a smooth descent in rates, but still holds ballast for sticky inflation or geopolitical flare-ups. It’s the Bridgewater playbook: own multiple uncorrelated return streams so that one macro miss doesn’t sink the ship.

DISCLAIMER: This analysis of the aforementioned stock security is in no way to be construed, understood, or seen as formal, professional, or any other form of investment advice. We are simply expressing our opinions regarding a publicly traded entity.

MACROHINT

MACROHINT

Bridgewater’s New Q2 2025 Positions: Dalio’s Multi-Asset Playbook for a Tectonic Rate Shift